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Background: Measles is a highly infectious disease, and timely administration of two doses of vaccine can ensure
adequate protection against measles for all ages in a population. This study aims to estimate the proportion of
children aged 8 months to 6 years vaccinated on time with measles-containing vaccines (MCV) and vaccinated
during the 2008 and 2010 measles supplementary immunization activities. This study also characterizes differences
in mean age at vaccination and vaccination timeliness by demographic characteristics, and describes maternal
knowledge of measles vaccination.
Methods: Immunization records were selected from a convenience sample of immunization clinics in Tianjin, China.
From the records, overall vaccination coverage and timely vaccination coverage were calculated for different
demographic groups. Mothers were also interviewed at these clinics to ascertain their knowledge of measles vaccination.
Results: Within the 329 immunization clinic records, child’s birth year and district of residence were found to be
significant predictors of different measures of vaccine timeliness. Children born in 2009 had a lower age at MCV dose 2
administration (17.96 months) than children born in 2005 (22.00 months). Children living in Hebei, a district in the
urban center of Tianjin were less likely to be vaccinated late than children living in districts further from the urban core
of Tianjin. From the 31 interviews with mothers, most women believed that timely vaccination was very important and
more than one dose was very necessary; most did not know whether their child needed another dose.
Conclusions: When reviewing MCV coverage in China, most studies do not consider timeliness. However, this study
shows that overall vaccination coverage can greatly overestimate vaccination coverage within certain segments of the
population, such as young infants.
Keywords: China, Measles, Measles vaccine, Measles-mumps-rubella vaccine, Vaccination knowledge, Vaccination
timeliness, Supplementary immunization activitiesBackground
Measles is an airborne viral disease characterized by
fever, cough, coryza, conjunctivitis, and a maculopapular
rash, and it is treated with supportive care. While most
cases recover within 3 weeks, measles can result in ser-
ious and potentially fatal complications, including diar-
rhea, pneumonia, blindness, and encephalitis [1,2].* Correspondence: awag@umich.edu
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unless otherwise stated.China has committed to several national and supra-
national measles reduction goals, including reducing mea-
sles incidence by 90% and reducing measles mortality by
95% from 1965 to 1995 [3], reducing measles incidence by
90% from 2000 to 2010, and eliminating endemic trans-
mission of measles by 2012 [4], though this last goal was
not met [5].
Morbidity and mortality from measles have decreased
worldwide in recent years because of these global elim-
ination efforts. The estimated number of measles deaths
worldwide decreased from 733,000 in 2000 to 158,000 in
2011 [1]. In that time frame, however, China has seenl Ltd. This is an Open Access article distributed under the terms of the Creative
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officially published national incidence rate increased
from 5.7 cases per 100,000 persons in 2000 to 9.56 cases
per 100,000 persons in 2005 [6] but then fell to 0.46
cases per 100,000 persons in 2012 [5]. The Municipality
of Tianjin has had similar cycles of measles outbreaks.
Between 2005 and 2008, measles incidence in Tianjin in-
creased from 7.64 to 16.10 cases per 100,000 persons. This
was followed by a period of decreasing case counts, after
which the reported measles incidence in Tianjin again in-
creased from 1.44 to 15.74 cases per 100,000 persons be-
tween 2009 and 2010 [Unpublished data, Tianjin Centers
for Disease Control and Prevention (CDC), 2014].
Measles is controlled through vaccination. China has
used a domestically-produced measles-containing vac-
cine (MCV) since 1966 [7]. Efficacy of the first dose of
MCV (MCV1) is relatively low when the vaccine is ad-
ministered before the child is one year of age. A review
of 70 studies showed vaccine efficacy of 84.0% at 9 to
11 months of age, and 92.5% at 12 months of age or
greater [8]. After a second dose of MCV, over 96% of
children will have immunity to measles [9]. Therefore, a
two-dose measles immunization schedule is necessary
in order to ensure adequate herd immunity of this
highly infectious disease within a population. A case–
control study in China found that the odds of acquiring
measles among those with only one MCV dose were not
significantly lower than the unvaccinated children; how-
ever, those with at least two doses of MCV did have sig-
nificantly lower odds of acquiring measles than the
unvaccinated children [10].
Currently, the immunization schedule in Tianjin in-
cludes three MCV doses: MCV1 is a single-antigen measles
vaccine given at 8 months of age, MCV2 is a measles-
mumps-rubella vaccine (MMR) given at 18 to 24 months
of age, and MCV3 is a second dose of MMR given at 5 years
of age [11]. Most Western countries with low incidence of
measles, such as the United States, follow a 2-dose MCV
schedule, with MCV1 administered only at 1 year of age or
older. Because of the relatively low effectiveness of MCV
before 1 year of age [8], MCV administered before the child
is 1 year of age in the US is not counted toward the 2-dose
schedule, and 2 doses would still need to be administered
to such a child after the child is 1 year of age [12]. Be-
cause of the higher incidence of measles in China, and
because of the relatively high burden of measles in in-
fants younger than 1 year of age [Unpublished data,
Tianjin CDC, February 8, 2013], MCV1 is administered
at less effective ages in China. However 2 doses are still
given after the child is 1 year of age to ensure that ad-
equate herd immunity can be established.
The World Health Organization (WHO) supports deliv-
ery of MCV2 through routine immunization services and
through supplementary immunization activities (SIAs),which were successful in eliminating measles in the Amer-
icas in the 1990s and early 2000s [13]. “Catch-up” SIAs
target all children within a particular age group and “fol-
low-up” SIAs target children born since the previous SIA
[1]. For example, Tianjin and other provinces in China im-
plemented a catch-up SIA in 2008 which targeted all chil-
dren aged 8 months to 14 years of age, regardless of prior
vaccination status. The SIAs delivered 1.3 million doses in
Tianjin and 46.5 million doses total throughout China. The
2010 follow-up SIA targeted all children aged 8 months to
4 years in Tianjin, regardless of vaccination status; 450,000
doses were delivered in Tianjin, and 102.3 million doses
were delivered in China [14].
Maternal knowledge of a certain vaccine may affect
vaccine timeliness. One study of caregivers of infants in
China showed that infants whose caregivers scored
lower on vaccine knowledge had higher prevalence of
delayed hepatitis B immunization at 12 months of age
compared to caregivers with the highest knowledge
score [15]. Moreover, parents aware of the necessity and
importance of timely vaccination are more likely to vac-
cinate their child on time [16,17].
The degree of delay in measles vaccinations and know-
ledge regarding measles vaccinations in Tianjin, China,
are of particular interest because of the difficulties in re-
ducing measles incidence in the elimination phase of
disease control. This study aims to estimate the propor-
tion of children aged 8 months to 6 years who were vac-
cinated on time with MCVs and vaccinated during the
2008 and 2010 SIAs. This study also characterizes differ-
ences in mean age at vaccination and describes maternal
knowledge of measles vaccination.
Methods
From June to August 2011, 4 immunization clinics were
visited in Tianjin, a municipality in northeastern China.
Tianjin had 12.9 million residents in its 2010 census; 4.3
million lived in the heavily urbanized central districts,
5.0 million lived in suburb districts, and 3.6 million lived
in rural districts [18]. Urban areas in Chinese cities are
generally wealthier than non-urban areas [19], and gen-
erally have been developing faster compared to non-
urban areas [20].
Immunization clinics serve specific geographical re-
gions, and all children in Tianjin receive measles vaccina-
tions at these government-funded clinics. Each district has
approximately 10 to 20 immunization clinics. Children
generally do not attend multiple clinics over the course of
their childhood unless their family moves to a different
area, in which case their record would be transferred to
that new area.
We selected four clinics, one from each of the follow-
ing districts: Hebei (urban), Binhai (suburban), Ninghe
(rural), and Wuqing (rural). These clinics were selected
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sented the diversity of different residential environments
(i.e. urban, suburban, and rural) within Tianjin. Two
rural clinics were chosen to increase the sample size
from that setting. At each clinic a review of a random
sample of immunization records was conducted. Add-
itionally, at the same clinics where records were sam-
pled, a sample of mothers accompanying their children for
immunization appointments was selected, and the mothers
were interviewed individually about their knowledge of
measles vaccination and their child’s immunization history.
Although this immunization history was similar to the in-
formation collected as part of the record review, data from
the mother interviews were not added to the record review
because of the different sampling techniques.
Record review
At each of these clinics, a sample of vaccination records
was reviewed for MCV information. Paper records were
first ordered by birth year, and the number of children
in each birth year was tallied. Within each birth year be-
tween 2005 and 2010, one-tenth of the records were se-
lected using a random numbers table. The study sample
size chosen was sufficient to evaluate the significance of
at least one month difference in mean age at vaccination
across birth years, assuming a standard deviation of one
month. District of residence, birthdate, sex, dates of MCV
administration, and MCV type (routine measles vaccine,
routine MMR, SIA measles vaccine) were abstracted from
each record onto a standardized data collection form. SIA
administration information was recorded in a special file
and in the child’s vaccine booklet at the time of the SIA,
and later transferred to the child’s permanent immunization
record in the clinic.
The following variables were derived from the vaccin-
ation records: child’s age (date of data collection minus
date of birth), child’s age at each vaccination (date of
vaccination minus date of birth), timely vaccination, and
SIA eligibility. Vaccinations were considered timely if ad-
ministration occurred within 8 months for MCV1, be-
fore 2 years for MCV2, and before 5 years 1 month for
MCV3. Eligibility for SIAs was defined as 8 months of
age and older for SIA 2008 or aged 8 months to 4 years
for SIA 2010. For both SIAs, subjects were designated
ineligible if vaccinated with an MCV in the 30 days be-
fore the SIA. Although the SIAs were carried out in
Ninghe, records from this district did not include SIA
vaccinations, so it was not possible to calculate SIA for
Ninghe district.
For routine immunizations, the mean ages at the three
MCV doses were calculated and stratified by child’s resi-
dent district, birth year, and sex. A non-parametric
Wilcoxon rank-sum test assessed significance of differ-
ences in mean age at vaccination between the sexes, andthe Kruskall-Wallis test evaluated the significance in
mean age at vaccination across birth years. The proportions
of subjects vaccinated in the 2008 and 2010 SIAs were also
calculated and stratified by district, birth year, and sex; sig-
nificance was assessed through a Fisher’s exact test.
Mother interviews
A small sample of mothers was chosen in order to per-
form a pilot study on the diversity of maternal knowledge
and attitudes towards measles vaccinations. All women
who came to the clinic for a vaccination appointment on
study days during June to August 2011 were invited to
participate in the study. If they were a mother of a child
aged 8 months to 6 years, they were interviewed after giv-
ing verbal consent. The mothers were asked about their
age, their highest level of completed education, and their
homes’ distance from the clinic in minutes travel time.
Knowledge about measles vaccination was assessed on a
three-point scale by asking mothers how important timely
vaccination was to protect their children from getting
measles (not important, somewhat important, or very im-
portant), how necessary more than one dose was to pro-
tect their children from getting measles (not necessary,
somewhat necessary, or very necessary), and whether their
child needed another dose (yes or no). The time required
to travel to the clinic from the client’s home was dichoto-
mized to 10 minutes or less and more than 10 minutes.
The record review sample size calculation used nQuery
(Statistical Solutions Ltd, Boston, MA). The data collection
forms for both the record review and mother interviews
were entered into databases in OpenClinica (OpenClinica,
LLC, Waltham, MA) with double data entry. All analyses
were performed with SAS, v. 9.2 (SAS Institute, Cary, NC).
The study was approved by the institutional review
board at the University of Michigan, Ann Arbor, and the
ethical review committee at the Tianjin Centers for Dis-
ease Control and Prevention in Tianjin, China, deter-
mined that the project was exempt from ethical review.
Results
Record review
Of the 329 children whose records were reviewed, there
were approximately equal numbers of each sex, 258
(78.4%) came from Hebei district, and all birth year co-
horts had at least 40 children (Table 1). Administration
of MCV1 was recorded for 324 children, the average
age at MCV1 was 8.46 months, and most children
(87.5%) were vaccinated on time. For MCV2, 265 chil-
dren had a record of administration, the average age at
MCV2 was 20.54 months, and a large majority of children
(93.1%) were vaccinated on time. MCV3 was recorded for
67 children, the average age at MCV3 was 5.04 years, and
slightly more than three-fourths of children who were eli-
gible for vaccination were vaccinated on time (Table 1).
Table 1 Mean age at vaccination and prevalence of on-time vaccination among children in Tianjin, China,
summer 2011
MCV dose 1a MCV dose 2b MCV dose 3c
Mean age in
months at
vaccination (SD)
Number
vaccinated
on-time (%)
Mean age in
months at
vaccination (SD)
Number vaccinated
on-time (%)
Mean age in
years at
vaccination (SD)
Number vaccinated
on-time (%)
Total number
Overall 8.46 (0.78) 288 (87.5%) 20.54 (2.94) 246 (93.1%) 5.04 (0.14) 52 (76.5%) 329
Sex
Female 8.37 (0.54) 156 (90.2%) 20.68 (2.86) 131 (94.2%) 5.05 (0.17) 30 (73.2%) 173
Male 8.57 (0.97) 132 (84.6%) 20.37 (3.02) 115 (91.3%) 5.03 (0.03) 22 (81.5%) 156
Districtd
Binhai 8.82 (0.91) 30 (63.8%) 22.48 (5.40) 24 (68.6%) 5.07 (0.09) 3 (27.3%) 47
Hebei 8.38 (0.70) 239 (92.6%) 20.13 (1.82) 207 (98.6%) 5.04 (0.09) 46 (92.0%) 258
Ninghe 8.84 (1.48) 9 (75.0%) 20.56 (2.14) 9 (81.8%) 5.01 (0.00) 1 (33.3%) 12
Wuqing 8.55 (0.60) 10 (83.3%) 23.36 (7.07) 6 (66.7%) 5.07 (0.57) 2 (50.0%) 12
Birth year
2005 8.59 (0.97) 37 (90.2%) 22.00 (4.71) 36 (87.8%) 5.07 (0.15) 30 (73.2%) 41
2006 8.42 (0.37) 50 (94.3%) 21.76 (3.30) 49 (92.5%) 4.99 (0.11) 22 (81.5%) 53
2007 8.50 (0.59) 48 (85.7%) 20.61 (1.49) 53 (94.6%) - - 56
2008 8.35 (0.66) 50 (94.3%) 20.10 (1.86) 50 (94.3%) - - 53
2009 8.59 (1.12) 47 (77.1%) 18.83 (1.45) 54 (93.1%) - - 61
2010 8.37 (0.75) 56 (86.2%) 17.96 (0.03) 4 (100.0%) - - 65
MCV, measles-containing vaccine.
SD, standard deviation.
a329 children were eligible for MCV1. Children 8 months of age or older were included. On-time vaccination is defined as administration before the infant is
9 months of age.
b265 children were eligible for MCV2. Children 18 months of age or older were included. On-time vaccination is defined as administration before the child is
2 years of age.
c68 children were eligible for MCV3. Children 5 years of age or older were included. On-time vaccination is defined as administration before the child is 5 years
1 month of age.
dOnly one clinic per district was selected.
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mean age at vaccination or vaccination timeliness. Age at
MCV1 administration (P = 0.0003), MCV2 administration
(P < 0.0001), and MCV3 administration (P = 0.0019) dif-
fered by birth year. Compared with children from other
districts, children living in Hebei district had the highest
prevalence of timely vaccination (P < 0.0001 for all three
MCVs).
Of 136 children eligible for the 2008 SIA, 121 (89.0%)
participated. Of 197 children eligible for the 2010 SIA,
123 (62.4%) participated. For both SIAs, variation in par-
ticipation by sex and across district of residence was not
statistically significant (Table 2).
Mother interviews
A total of 42 women were approached to be interviewed
in the immunization clinics. Eight were ineligible to par-
ticipate in the study because their infants were younger
than 8 months of age. Three mothers were eligible but
chose not to participate in the study. Table 3 shows the
demographic characteristics of the participants. Of the
31 total participants, 23 (74.2%) were from Hebei districtand the rest were from Binhai, Ninghe, or Wuqing dis-
tricts. The mothers were evenly divided between those
who had completed college (15, 48.4%) and those who
had lower levels of education. Most women (22, 75.9%)
lived ≤10 minutes from the clinic.
Mothers’ attitude towards and knowledge of measles vac-
cines was assessed through three questions. A large major-
ity of mothers (29, 90.3%) believed that timely vaccination
was “very important.” A slight majority (18, 58.1%) believed
that more than one dose of MCV was “very necessary” to
protect their child. About two-thirds (67.7%) of mothers
did not know whether their child needed another dose
or not.
Mother’s attitude towards measles vaccination was not
significantly associated with most other variables. The
number of women indicating that more than one MCV
dose was “very necessary” to protect their child did not
vary across district (P = 0.12), child’s birth year (P = 0.62),
child’s sex (P = 0.92), mother’s highest education level (P =
0.34), minutes from clinic (P = 0.60), or vaccine timeliness
(P = 0.37). However, the number of women indicating that
more than one dose of MCV was “very necessary” did
Table 2 Participation in measles SIAs among children in
Tianjin, China, summer 2011
Participated in
2008 SIAa (%)
Participated in
2010 SIAb (%)
Overall 121 (89.0%) 123 (62.4%)
Sex
Female 66 (88.6%) 64 (63.4%)
Male 55 (88.2%) 59 (61.5%)
Districtc
Binhai 4 (44.4%) 7 (63.6%)
Hebei 116 (95.9%) 110 (61.5%)
Wuqing 5 (83.3%) 6 (85.7%)
Birth year
2005 31 (88.6%) 3 (37.5%)
2006 39 (83.0%) 17 (36.2%)
2007 45 (93.8%) 22 (44.9%)
2008 6 (100.0%) 40 (87.0%)
2009 - 41 (95.4%)
2010 - 0
SIA, supplementary immunization activity.
a136 children were eligible for the 2008 SIA (41.3% of the study population).
Children were eligible if they had no measles-containing vaccine in the previous
month and if they were 8 months of age or older at the time of the SIA.
b197 children were eligible for the 2010 SIA (59.9% of the study population).
Children were eligible if they had no measles-containing vaccine in the previous
month and if they were 8 months to 4 years of age at the time of the SIA.
cOnly one clinic per district was selected.
Table 3 Demographic characteristics and attitudes
toward measles vaccine in a sample of mothers in
Tianjin, China, summer 2011
Number %
Overall 31 100
Child’s sex
Female 17 54.8
Male 14 45.2
District
Binhai 4 12.9
Hebei 23 74.2
Ninghe 2 6.5
Wuqing 2 6.5
Mother’s agea
< 28 years 7 23.3
28 to <30 years 4 13.3
30 to <32 years 10 33.3
≥ 32 years 9 30.0
Mother’s highest education
Middle school 8 25.8
High school 4 12.9
Vocational education 3 9.7
Junior college 1 3.2
College or above 15 48.4
Minutes from clinica
≤ 10 minutes 22 75.9
> 10 minutes 7 24.1
Importance of on-time measles vaccination
Not important 0 0
Somewhat important 2 6.5
Very important 28 90.3
I do not know 1 3.2
Necessity of more than one dose of measles vaccine
Not necessary 0 0
Somewhat necessary 11 35.5
Very necessary 18 58.1
I do not know 2 6.5
Child needs another dose of measles vaccine
Yes 6 19.4
No 4 12.9
I do not know 21 67.7
aData were missing for 1 mother about age and for 2 mothers about distance
from the clinic.
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mothers younger than 28 years thought more than one
dose to be very necessary, whereas 88.9% of mothers
greater than or equal to 32 years of age thought this.
Discussion
Measles vaccination is an important indicator of pro-
gress toward the fourth Millennium Development Goal
of reducing the under-5 mortality rate [1,4]. However,
for immunization programs to successfully combat mea-
sles, vaccination of children needs to be timely and two
doses are required [9,10]. We found levels of timely
MCV1 administration to be lower than 90% in children
living in Tianjin, China. Given that measles vaccine is
only about 84.0% effective at this age [8], the establish-
ment of herd immunity may be delayed in this population
and more infants may be at risk of acquiring measles than
indicated by an MCV1 coverage estimate that does not
consider timeliness. Moreover, timely vaccination of
MCV2 varied across time and geography, indicating that
measles susceptibility in Tianjin varies by residence and by
birth cohort.
When reviewing MCV coverage in China, studies typic-
ally do not consider timeliness [21]. However, this study
shows that only looking at overall vaccination coverage,
and not timeliness, can greatly overestimate vaccinationcoverage within certain segments of the population, like
young infants. For example, in this study, 98.5% of the
children had been vaccinated with MCV1 but only 87.5%
had been vaccinated on-time. These figures are similar to
a 2011 internal report of the Tianjin CDC, which showed
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only 85.9% had been vaccinated on time [Personal Com-
munication, Tianjin CDC, 2011]. Considering that infants
are at high risk for acquiring measles, timely vaccination is
important. Reporting vaccination coverage, instead of
timely vaccination coverage, may not provide the true pic-
ture of protection against measles in the population of
young infants.
Of the 136 children eligible for the 2008 SIA in this
study, only 88.4% participated; 62.4% of the 197 eligible
children participated in the 2010 SIA. These are lower
estimates than those previously described. For example,
a report from the Tianjin Beichen district CDC of 71,581
children between 8 months and 14 years of age with
electronic vaccination records found a very high (99.8%)
level of participation in the 2008 SIA [22]. The age range
for the study in Beichen district had a higher bound than
in our study (7 years of age). The study in Beichen dis-
trict did not report SIA participation by age, but if older
ages had higher participation, then the findings in our
two studies may not be directly comparable. Our study
may also have underestimated SIA participation because
children should not receive an MCV within 28 days of
another live vaccine, such as oral polio or varicella if not
administered simultaneously [23]. However, only infor-
mation on MCV administration was collected for this
study; children receiving oral polio or varicella could
have also been ineligible but would have still been consid-
ered eligible in our calculations. Low SIA estimates may
also result from a child’s SIA record not being transferred
to the clinic records; this was considered a low possibility,
however, because the original record was recorded both in
the child’s vaccine booklet and in a special file. Clinics used
both of these documents to update children’s records.
Lastly, the low estimate of SIA participation in this study
could represent a reduced willingness of Chinese parents to
participate in the SIAs, the effect of which could vary across
districts. These SIAs targeted children regardless of their
vaccination status, and future research could investigate po-
tential parental fatigue from receiving multiple doses of the
same vaccine through both routine immunization services
and SIAs.
From the 31 interviews with mothers in this study,
most women believed that timely vaccination was very
important and more than one dose was very necessary,
but most did not know whether their child needed an-
other dose. Because of the small sample size, we did not
relate maternal knowledge to vaccination outcomes in the
child. Other studies, like that by Richards and Sheridan in
Australia, have found that maternal knowledge of the vac-
cine was important for predicting vaccine timeliness [16].
In a survey of migrants and migrant children in Zhejiang
province, China, maternal attitudes and knowledge, in-
cluding perception of vaccine necessity and knowledge ofthe immunization schedule, were associated with measles
vaccination and timeliness of measles vaccination [24].
In previous studies, factors such as mother’s education
level and age have been related to mother’s knowledge
of vaccination. Although we did not see a significant dif-
ference across maternal age, one study in Gansu, China
[15] did show mother’s education level to be related to
various child vaccine statuses. Necessity of more than one
dose of MCV did vary by mother’s age in our study; older
mothers were more aware of the necessity of more than
one dose of MCV. Studies in the United States [25] and
Kenya [26] have similarly found maternal age to affect
child vaccination status. This finding could be a result of
mothers being more experienced with the vaccination pro-
grams from previous children, though this is likely to be
less of a factor in China because of its One Child Policy.
Another limitation to the study was that most partici-
pants came from Hebei (79.12% of records and 74.19%
of mothers), a wealthier, urbanized district in Tianjin.
The high proportion of participants from Hebei could
lead to results unrepresentative of Tianjin as a whole. In
addition, because we purposely chose each clinic, they
may not be representative of the urban-suburban div-
ision in Tianjin. Instead, they reflect some of the diver-
sity seen in vaccination outcomes throughout the city.
Because we only included the immunization history
from children who had attended an immunization clinic
and only interviewed mothers who brought their chil-
dren to immunization clinics, the possibility of selection
bias exists. We may have underestimated vaccination
outcomes in the record review and our study’s mothers
may have been more knowledgeable than mothers who
did not attend the immunization clinic. Attendance at
immunization clinics in China is not well documented,
but one study among parents who recently moved from
rural areas to Beijing found that 11.9% of them had not
yet brought their child to an area immunization clinic
[27]. Future studies with a larger sample size will be bet-
ter able to analyze the relationship between attitudes to-
wards vaccination and vaccination completeness or
timeliness in China, and these studies could also include
provider-level variables such as availability of vaccines
at clinics.
Conclusion
Measles is a difficult-to-control infectious disease because
of its high degree of communicability, resulting in the ne-
cessity of a two-dose immunization schedule. China has
attempted to deliver this second dose through the routine
immunization program augmented by supplementary
immunization activities. This study found decreases in
mean age of vaccination, especially for MCV2, over time,
but important differences in vaccination timeliness across
different geographical regions mean that susceptible
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coverage of MCV. Reporting of vaccination coverage
should include statistics on whether administration of the
dose was on time, especially for countries like China that
are trying to eliminate measles. This information is particu-
larly important for highly infectious diseases like measles,
pertussis, and varicella, which require a high threshold
of timely vaccination to stop the spread of disease in
young infants.
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